IntrOp's Mobetron enters China:
This article was originally published in Clinica
Executive Summary
IntrOp Medical has expanded its presence in Asia with the sale of its first Mobetron electron beam system in China. The Sunnyvale, California-based company sold the system to Beijing Tumor Hospital, part of Beijing University Medical Center. The Mobetron, which costs in excess of $1m per system, is used to perform intraoperative electron radiation therapy (IOERT), and can be easily transported from one operation room to another without being restricted to a radiation-shielded surgical suite. This Chinese order brings the total number of Mobetron systems sold worldwide to 19. The device has been installed in hospitals across Europe, the US and Japan.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.